NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 937 filers reported holding NOVARTIS A G in Q3 2017. The put-call ratio across all filers is 0.64 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $935,539 | +30.7% | 9,277 | +19.2% | 0.03% | +39.1% |
Q1 2023 | $716,009 | +16.4% | 7,783 | +14.7% | 0.02% | 0.0% |
Q4 2022 | $615,386 | +195.9% | 6,783 | +177.1% | 0.02% | +283.3% |
Q2 2022 | $208,000 | -92.2% | 2,448 | -92.1% | 0.01% | -94.3% |
Q3 2018 | $2,671,000 | +6.6% | 30,996 | -6.5% | 0.10% | +6.1% |
Q2 2018 | $2,505,000 | +47.4% | 33,164 | +58.7% | 0.10% | +43.5% |
Q1 2018 | $1,699,000 | +36.9% | 20,901 | +41.4% | 0.07% | +23.2% |
Q4 2017 | $1,241,000 | +0.3% | 14,781 | +2.6% | 0.06% | -16.4% |
Q3 2017 | $1,237,000 | +6.1% | 14,408 | +3.1% | 0.07% | -30.9% |
Q2 2017 | $1,166,000 | +26.1% | 13,972 | +12.2% | 0.10% | +5.4% |
Q1 2017 | $925,000 | +21.4% | 12,457 | +19.0% | 0.09% | 0.0% |
Q4 2016 | $762,000 | +9.5% | 10,465 | +18.8% | 0.09% | 0.0% |
Q3 2016 | $696,000 | -4.7% | 8,809 | -0.5% | 0.09% | -10.7% |
Q2 2016 | $730,000 | -46.6% | 8,853 | -53.1% | 0.10% | +22.6% |
Q1 2016 | $1,366,000 | +76.3% | 18,860 | +109.4% | 0.08% | -14.3% |
Q4 2015 | $775,000 | -56.7% | 9,007 | -50.5% | 0.10% | -58.8% |
Q2 2015 | $1,789,000 | +31.3% | 18,190 | +31.6% | 0.24% | -12.8% |
Q1 2015 | $1,363,000 | – | 13,827 | – | 0.27% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GODSEY & GIBB, INC | 184,900 | $15,121,000 | 6.74% |
Martin Investment Management, LLC | 289,924 | $23,710,000 | 5.98% |
Camber Capital Management LP | 2,000,000 | $163,560,000 | 5.04% |
MANAGED ASSET PORTFOLIOS, LLC | 381,778 | $31,222,000 | 4.76% |
PROFESSIONAL ADVISORY SERVICES INC | 267,779 | $21,899,000 | 3.22% |
SCHARF INVESTMENTS, LLC | 1,244,711 | $101,794,000 | 3.21% |
GARLAND CAPITAL MANAGEMENT INC | 50,755 | $4,151,000 | 2.97% |
First Fiduciary Investment Counsel, Inc. | 167,378 | $13,688,000 | 2.67% |
WILKINS INVESTMENT COUNSEL INC | 130,590 | $10,680,000 | 2.61% |
Lowell Blake & Associates Inc. | 66,309 | $5,423,000 | 2.52% |